FINWIRES · TerminalLIVE
FINWIRES

Mitsubishi Electric's Fiscal-Year Profit Jumps 26%

By

-- Mitsubishi Electric's (TYO:6503) profit attributable to owners of the parent jumped 26% to 407.7 billion yen for the fiscal year ended March 31 from 324 billion yen a year earlier.

The electronics company's earnings per share increased to 198.31 yen from 155.70 yen a year ago, according to a Tokyo bourse filing on Tuesday.

Revenue climbed 7% to 5.895 trillion yen from 5.522 trillion yen in the prior year.

It declared a final dividend of 30 yen per share for the fiscal 2026, payable from June 2.

For the fiscal year ending March 31, 2027, the company expects attributable profit of 475 billion yen and net sales of 6.2 trillion yen.

Mitsubishi Electric plans to pay interim and year-end dividends of 25 yen and 30 yen per share, respectively, for the current fiscal year (total 55 yen), which is higher than the amount paid in the year-ago period.

Related Articles

International

U.S. Energy Production Climbs 3% YoY in January, EIA Reports

U.S. primary energy production rose 3% year over year in January to 9.1 quadrillion British thermal units, the U.S. Energy Information Administration said in its Monthly Energy Review released Monday.Total fossil fuels production in January was made up of 46% dry natural gas, 31% crude oil, 12% crude oil and 11% natural gas plant liquids, the EIA reported.Total renewable energy production was composed of 56% biomass, 20% wind, 12% hydroelectric power, 11% solar and 1% geothermal energy, according to the agency.U.S. natural gas plant liquids production was 7% higher in January than in the year-ago month. Dry natural gas production and renewable energy production each climbed 4%. Nuclear electric power production and coal production each increased 2%. Crude oil production rose 1%.

$CLX1$LCOX1$NGV1$UNG$UNL$USO
Asia

CanSino Biologics Widens Loss in Q1

CanSino Biologics (HKG:6185, SHA:688185) widened its attributable loss in the first quarter of 2026 to 40.4 million yuan from 11.5 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.Loss per share was 0.16 yuan, compared with 0.05 yuan in the corresponding period of the previous fiscal year.Operating revenue jumped 39% to 190.3 million yuan from 137.2 million yuan in the year-ago period, amid the company's expanding commercial product portfolio, increasing overseas presence, and robust sales of hte MCV4 vaccine.The vaccine manufacturer attributed the wider loss to a higher operating cost; a rise in selling, administrative, and R&D expenses; and a lower other income related to government grants and international funding support.

$HKG:6185$SHA:688185
Japan

WTI Crude Oil Futures Jump 3.5% to $99.72 Pre-Bell; Brent Futures Rise 2.9% to $111.39